- Home
- APLM vs CEAD Comparison
APLM vs CEAD Comparison
Compare APLM & CEAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLM
- CEAD
- Stock Information
- Founded
- APLM 2016
- CEAD 2009
- Country
- APLM United States
- CEAD United States
- Employees
- APLM N/A
- CEAD N/A
- Industry
- APLM Blank Checks
- CEAD Industrial Machinery/Components
- Sector
- APLM Finance
- CEAD Industrials
- Exchange
- APLM Nasdaq
- CEAD Nasdaq
- Market Cap
- APLM 7.7M
- CEAD 6.9M
- IPO Year
- APLM N/A
- CEAD N/A
- Fundamental
- Price
- APLM $6.16
- CEAD $8.51
- Analyst Decision
- APLM Strong Buy
- CEAD
- Analyst Count
- APLM 2
- CEAD 0
- Target Price
- APLM $425.00
- CEAD N/A
- AVG Volume (30 Days)
- APLM 42.6K
- CEAD 22.6K
- Earning Date
- APLM 04-15-2025
- CEAD 03-27-2025
- Dividend Yield
- APLM N/A
- CEAD N/A
- EPS Growth
- APLM N/A
- CEAD N/A
- EPS
- APLM N/A
- CEAD N/A
- Revenue
- APLM $2,101,000.00
- CEAD $2,803,470.00
- Revenue This Year
- APLM N/A
- CEAD N/A
- Revenue Next Year
- APLM N/A
- CEAD N/A
- P/E Ratio
- APLM N/A
- CEAD N/A
- Revenue Growth
- APLM 70.54
- CEAD N/A
- 52 Week Low
- APLM $6.20
- CEAD $5.60
- 52 Week High
- APLM $63.00
- CEAD $12.26
- Technical
- Relative Strength Index (RSI)
- APLM 42.37
- CEAD 46.10
- Support Level
- APLM $6.50
- CEAD $7.90
- Resistance Level
- APLM $8.00
- CEAD $9.45
- Average True Range (ATR)
- APLM 1.36
- CEAD 0.86
- MACD
- APLM -0.22
- CEAD 0.04
- Stochastic Oscillator
- APLM 5.93
- CEAD 50.15
About APLM Apollomics Inc.
Apollomics Inc is an innovative clinical-stage biopharmaceutical company focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company lead programs include vebreltinib (APL-101), a potent, selective c-Met inhibitor for the treatment of non-small cell lung cancer and other advanced tumors with c-Met alterations, and uproleselan (APL-106), a specific E-Selectin antagonist that has the potential to be used adjunctively with standard chemotherapy to treat acute myeloid leukemia.
About CEAD CEA Industries Inc.
CEA Industries Inc through its subsidiary is focused on selling environmental control and other technologies and services to the Controlled Environment Agriculture ("CEA") industry. The company provides integrated mechanical, electrical, and plumbing ("MEP") engineering design, proprietary and curated environmental control equipment, and automation offerings that serve the CEA industry. The Company has one operating segment that is dedicated to the manufacture and sale of its products.